OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery, Function, and Therapeutic Targeting of Siglec-8
Bradford A. Youngblood, John Leung, Rustom Falahati, et al.
Cells (2020) Vol. 10, Iss. 1, pp. 19-19
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances
Allen P. Kaplan, Mark Lebwohl, Ana M. Giménez‐Arnau, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 389-401
Open Access | Times Cited: 87

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
Simon Gebremeskel, Julia Schanin, Krysta M. Coyle, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 97

Siglec Ligands
Anabel Gonzalez-Gil, Ronald L. Schnaar
Cells (2021) Vol. 10, Iss. 5, pp. 1260-1260
Open Access | Times Cited: 73

The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria
Bingjing Zhou, Jie Li, Runqiu Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56

Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases
Martin Metz, Pavel Kolkhir, Sabine Altrichter, et al.
Allergy (2023) Vol. 79, Iss. 1, pp. 37-51
Open Access | Times Cited: 30

Eosinophils as potential biomarkers in respiratory viral infections
Iole Macchia, Valentina La Sorsa, Francesca Urbani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28

Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort
Guillaume Lefèvre, S. Bleuse, Mathieu Puyade, et al.
Allergy (2025)
Closed Access | Times Cited: 1

Eosinophils in skin diseases
Susanne Radonjic‐Hoesli, Marie‐Charlotte Brüggen, Laurence Feldmeyer, et al.
Seminars in Immunopathology (2021) Vol. 43, Iss. 3, pp. 393-409
Open Access | Times Cited: 48

Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity
Peter Valent, Lina Degenfeld-Schonburg, Irina Sadovnik, et al.
Seminars in Immunopathology (2021) Vol. 43, Iss. 3, pp. 423-438
Open Access | Times Cited: 44

Lirentelimab for severe and chronic forms of allergic conjunctivitis
Stephen D. Anesi, Joseph Tauber, Quan Dong Nguyen, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 3, pp. 631-639
Open Access | Times Cited: 35

Eosinophilic esophagitis: Immune mechanisms and therapeutic targets
Dilawar Khokhar, Sahiti Marella, Gila Idelman, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 10, pp. 1142-1156
Open Access | Times Cited: 32

The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs
Erminia Ridolo, Alessandro Barone, Martina Ottoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1702-1702
Open Access | Times Cited: 7

Siglecs as Therapeutic Targets in Cancer
Jackwee Lim, Duygu Sari, Tanaya Bagga
Biology (2021) Vol. 10, Iss. 11, pp. 1178-1178
Open Access | Times Cited: 40

EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 17-38
Open Access | Times Cited: 33

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation
Wouter Korver, Alan Wong, Simon Gebremeskel, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25

The multidisciplinary approach to eosinophilia
Gunhild Nynke Thomsen, Mette Christoffersen, Hanne Lindegaard, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14

Siglecs in allergy and asthma
Bruce S. Bochner, Jeremy A. O’Sullivan, Alan T. Chang, et al.
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101104-101104
Open Access | Times Cited: 19

Human sialoglycan ligands for immune inhibitory Siglecs
Anabel Gonzalez-Gil, T. August Li, Jean Kim, et al.
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101110-101110
Open Access | Times Cited: 19

Comorbidities of Chronic Urticaria: A glimpse into a complex relationship
Niki Papapostolou, Paraskevi Xepapadaki, Alexander Katoulis, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 19

Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access

Heterogeneity of Intestinal Tissue Eosinophils: Potential Considerations for Next-Generation Eosinophil-Targeting Strategies
Joanne C. Masterson, Calies Menard‐Katcher, Leigha D. Larsen, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 426-426
Open Access | Times Cited: 25

Mast Cells as Important Regulators in Autoimmunity and Cancer Development
Christine Noto, Stella G. Hoft, Richard J. DiPaolo
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 24

Eosinophilic esophagitis: New molecules, better life?
Angela Y. Lam, Christopher Ma, Jeffrey K. Lee, et al.
Current Opinion in Pharmacology (2022) Vol. 63, pp. 102183-102183
Open Access | Times Cited: 16

Role of Siglecs in viral infections: A double-edged sword interaction
Dàlia Raϊch‐Regué, Patricia Resa‐Infante, Marçal Gallemí, et al.
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101113-101113
Open Access | Times Cited: 16

CX3CR1+ Macrophage Facilitates the Resolution of Allergic Lung Inflammation via Interacting CCL26
Hyung‐Geun Moon, Seung-Jae Kim, Ki Hyun Kim, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 11, pp. 1451-1463
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top